IHS Chemical Week

Regions :: Western Europe :: Switzerland

Roche to invest $209 million to build ADC facility

7:16 AM MDT | October 14, 2013 | Deepti Ramesh

Roche (Basel, Switzerland) says it will invest 190 million Swiss francs ($209 million) in the construction of a new production facility at Basel, which will support the manufacturing of antibody-drug conjugate (ADC) medicines. ADCs offer a new treatment method for cancer in which cancer cells are destroyed in a more targeted way, and healthy cells are less affected. The investment at Basel is expected to create 50 jobs. The construction of the new production facility will begin in January 2014; production at the unit will start by August 2016. “The...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers

 

 

 













 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2012 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa